Page 6 - Repligen Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Repligen (NASDAQ:RGEN – Get Rating) and Acumen Pharmaceuticals (NASDAQ:ABOS – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation. Analyst Recommendations This is a summary of recent ratings and recommmendations […]

American Capital Management Inc. boosted its position in Repligen Co. (NASDAQ:RGEN – Get Rating) by 14.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 140,751 shares of the biotechnology company’s stock after purchasing an additional 17,827 shares during the quarter. American […]

American Capital Management Inc. lifted its holdings in Repligen Co. (NASDAQ:RGEN – Get Rating) by 14.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 140,751 shares of the biotechnology company’s stock after buying an additional 17,827 shares during the quarter. American Capital Management Inc. […]

The Manufacturers Life Insurance Company boosted its position in shares of Repligen Co. (NASDAQ:RGEN – Get Rating) by 1.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 55,557 shares of the biotechnology company’s stock after acquiring an additional 695 shares during the […]

The Business Research Company's Protein A Resin Global Market Report 2023 – Market Size, Trends, And Global Forecast 2023-2032